Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia
Wilma Barcellini(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Bruno Fattizzo(University of Milan)
Cited by 281
Related Papers
Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients
|Blood|2020|657
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients
|Blood|2014|371
Cold agglutinin disease revisited: a multinational, observational study of 232 patients
|Blood|2020|167
Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies
|Blood|2012|144
The Changing Landscape of Autoimmune Hemolytic Anemia
|Frontiers in Immunology|2020|141